Richard Saynor
ON THE RECORD · 5 verbatim quotes · every quote source-verified
“Any business is not going to systematically continue to supply a product at a material loss,”
Richard Saynor · said 2026-09-08 · reported 2026-09-08
Saynor explained that manufacturers could not continue supplying products at a loss if tariffs are imposed.
“There still remains a complex space requiring capital, scale, and technical expertise. The players that can do this are few and far between, and given the sheer scale and number of [loss of exclusivities] ahead, competitive intensity at asset level is expected to reduce,”
Richard Saynor · said 2026-09-08 · reported 2026-09-08
Saynor said biosimilars require capital, scale, and technical expertise, limiting the number of competitors in the space.
“billions of dollars, but I have no idea how many billions of dollars,”
Richard Saynor · said 2026-09-08 · reported 2026-09-08
Saynor was asked by CNBC to quantify the GLP-1 business opportunity for Sandoz.
“Patients pay the tariff,”
Richard Saynor · said 2026-09-08 · reported 2026-09-08
Sandoz CEO Richard Saynor warned that tariffs on generic drugs would ultimately be paid by American patients.
“So you either then have a choice of putting the price [up] or not supplying the product.”
Richard Saynor · said 2026-09-08 · reported 2026-09-08
Saynor said manufacturers would face a choice between raising prices or stopping supply of some medicines under tariffs.